MAFENIDE ACETATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mafenide acetate and what is the scope of freedom to operate?
Mafenide acetate
is the generic ingredient in two branded drugs marketed by Rising, Endo Operations, Novast Labs, and Mylan Institutional, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for mafenide acetate. Three suppliers are listed for this compound.
Summary for MAFENIDE ACETATE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 2 |
Patent Applications: | 1,451 |
Drug Prices: | Drug price trends for MAFENIDE ACETATE |
What excipients (inactive ingredients) are in MAFENIDE ACETATE? | MAFENIDE ACETATE excipients list |
DailyMed Link: | MAFENIDE ACETATE at DailyMed |
Recent Clinical Trials for MAFENIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Maricopa Integrated Health System | N/A |
PuriCore, Inc. | N/A |
Valleywise Health | N/A |
Pharmacology for MAFENIDE ACETATE
Drug Class | Methylated Sulfonamide Antibacterial |
Medical Subject Heading (MeSH) Categories for MAFENIDE ACETATE
Anatomical Therapeutic Chemical (ATC) Classes for MAFENIDE ACETATE
US Patents and Regulatory Information for MAFENIDE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 201511-001 | Feb 12, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 206716-001 | Jul 31, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Institutional | SULFAMYLON | mafenide acetate | FOR SOLUTION;TOPICAL | 019832-003 | Jun 5, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MAFENIDE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.